Supportive management strategies for disseminated intravascular coagulation
- 1 January 2016
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 115 (05) , 896-904
Abstract
The cornerstone of the management of disseminated intravascular coagulation (DIC) is the treatment of the underlying condition triggering the coagulopathy. However, a number of uncertainties remain over the optimal supportive treatment. The aim of this study was to provide evidence and expert-based recommendations on the optimal supportive haemostatic and antithrombotic treatment strategies for patients with DIC. A working group defined five relevant clinical scenarios. Published studies were systematically searched in the MEDLINE and EMBASE databases (up to May 2014). Seven internationally recognised experts were asked to independently provide clinical advice. A two-phase blinded data collection technique was used to reach consensus. Only three randomised controlled trials (RCTs) on the supportive management of DIC were identified. The RCTs (overall less than 100 patients) investigated the use of fresh frozen plasma and platelet transfusion and found no differences in survival between the intervention and control groups. The experts’ approach was heterogeneous, although there was consensus that supportive management should vary according to the underlying cause, clinical manifestations and severity of blood test abnormalities. Platelet transfusion should be given to maintain platelet count > 50×109/l in case of bleeding while a lower threshold of 20 to 30×109/l may be used in DIC without bleeding. Thromboprophylaxis with low-molecular-weight heparin is advised until bleeding ensues or platelet count drops below 30×109/l. In conclusion, in the absence of solid evidence from RCTs, an individualised supportive management of DIC is advisable based on the type of underlying disease, presence of bleeding or thrombotic complications and laboratory tests results. Supplementary Material to this article is available online at www.thrombosis-online.com.Keywords
This publication has 13 references indexed in Scilit:
- Bleeding and Coagulopathies in Critical CareNew England Journal of Medicine, 2014
- Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelinesJournal of Intensive Care, 2014
- Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelinesJournal of Thrombosis and Haemostasis, 2013
- Evidence and clinical judgment: Treatment of cerebral vein thrombosisThrombosis and Haemostasis, 2010
- A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsisBlood Coagulation & Fibrinolysis, 2006
- Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulationJournal of Thrombosis and Haemostasis, 2006
- Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trialsBritish Journal of Haematology, 2004
- Comparison of Solvent/Detergent-Inactivated Plasma and Fresh Frozen Plasma under Routine Clinical ConditionsTransfusion Medicine and Hemotherapy, 2000
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- Controlled study of treatment for disseminated intravascular coagulation in the neonateThe Journal of Pediatrics, 1982